{"count": 18, "results": [{"_id": "7572690", "pmid": 7572690, "title": "Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).", "journal": "Am J Cardiol", "authors": ["Kjekshus J", "Pedersen TR"], "date": "1995-09-28T00:00:00Z", "doi": "10.1016/s0002-9149(99)80473-1", "meta_date_publication": "1995 Sep 28", "meta_volume": "76", "meta_issue": "9", "meta_pages": "64C-68C", "score": 50075.25, "text_hl": "Reducing the risk of @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary@@@ events: evidence from the Scandinavian @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Survival Study (4S).", "citations": {"NLM": "Kjekshus J, Pedersen TR. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol. 1995 Sep 28;76(9):64C-68C. PMID: 7572690", "BibTeX": "@article{7572690, title={Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).}, author={Kjekshus J and Pedersen TR}, journal={Am J Cardiol}, volume={76}, number={9}, pages={64C-68C}}"}}, {"_id": "20716235", "pmid": 20716235, "title": "General practitioners' views and experiences of over-the-counter simvastatin in Scotland.", "journal": "Br J Clin Pharmacol", "authors": ["Stewart D", "Cunningham IT", "Hansford D", "John D", "McCaig D", "McLay J"], "date": "2010-09-01T00:00:00Z", "doi": "10.1111/j.1365-2125.2010.03701.x", "meta_date_publication": "2010 Sep", "meta_volume": "70", "meta_issue": "3", "meta_pages": "356-9", "score": 50066.797, "text_hl": "The majority (92.6%, 428) were aware that community pharmacists could sell @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ to reduce the risk of a first @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary@@@ event in individuals at moderate risk of CHD. ", "citations": {"NLM": "Stewart D, Cunningham IT, Hansford D, John D, McCaig D, McLay J. General practitioners' views and experiences of over-the-counter simvastatin in Scotland. Br J Clin Pharmacol. 2010 Sep;70(3):356-9. PMID: 20716235", "BibTeX": "@article{20716235, title={General practitioners' views and experiences of over-the-counter simvastatin in Scotland.}, author={Stewart D and Cunningham IT and Hansford D and John D and McCaig D and McLay J}, journal={Br J Clin Pharmacol}, volume={70}, number={3}, pages={356-9}}"}}, {"_id": "17336698", "pmid": 17336698, "title": "Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.", "journal": "Am J Kidney Dis", "authors": ["Chonchol M", "Cook T", "Kjekshus J", "Pedersen TR", "Lindenfeld J"], "date": "2007-03-01T00:00:00Z", "doi": "10.1053/j.ajkd.2006.11.043", "meta_date_publication": "2007 Mar", "meta_volume": "49", "meta_issue": "3", "meta_pages": "373-82", "score": 50063.35, "text_hl": "Rates of major @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary@@@ events (adjusted HR, 0.67; CI, 0.56 to 0.79) and @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary@@@ revascularization (adjusted HR, 0.62; CI, 0.49 to 0.77) also were significantly lower in the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ group. ", "citations": {"NLM": "Chonchol M, Cook T, Kjekshus J, Pedersen TR, Lindenfeld J. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency. Am J Kidney Dis. 2007 Mar;49(3):373-82. PMID: 17336698", "BibTeX": "@article{17336698, title={Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.}, author={Chonchol M and Cook T and Kjekshus J and Pedersen TR and Lindenfeld J}, journal={Am J Kidney Dis}, volume={49}, number={3}, pages={373-82}}"}}, {"_id": "15694936", "pmid": 15694936, "title": "Atheroma stabilizing effects of simvastatin due to depression of macrophages or lipid accumulation in the atheromatous plaques of coronary plaque-prone WHHL rabbits.", "journal": "Atherosclerosis", "authors": ["Shiomi M", "Yamada S", "Ito T"], "date": "2005-02-01T00:00:00Z", "doi": "10.1016/j.atherosclerosis.2004.10.024", "meta_date_publication": "2005 Feb", "meta_volume": "178", "meta_issue": "2", "meta_pages": "287-94", "score": 50058.85, "text_hl": "@DISEASE_Plaque_Atherosclerotic @DISEASE_MESH:D058226 @@@Atheroma@@@ stabilizing effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ due to @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@ of macrophages or @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ accumulation in the @DISEASE_Plaque_Atherosclerotic @DISEASE_MESH:D058226 @@@atheromatous plaques@@@ of @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary plaque@@@-prone WHHL @SPECIES_9986 @@@rabbits@@@.", "citations": {"NLM": "Shiomi M, Yamada S, Ito T. Atheroma stabilizing effects of simvastatin due to depression of macrophages or lipid accumulation in the atheromatous plaques of coronary plaque-prone WHHL rabbits. Atherosclerosis. 2005 Feb;178(2):287-94. PMID: 15694936", "BibTeX": "@article{15694936, title={Atheroma stabilizing effects of simvastatin due to depression of macrophages or lipid accumulation in the atheromatous plaques of coronary plaque-prone WHHL rabbits.}, author={Shiomi M and Yamada S and Ito T}, journal={Atherosclerosis}, volume={178}, number={2}, pages={287-94}}"}}, {"_id": "22740232", "pmid": 22740232, "title": "Pharmacists' perceived integration into practice of over-the-counter simvastatin five years post reclassification.", "journal": "Int J Clin Pharm", "authors": ["Paudyal V", "Hansford D", "Cunningham S", "Stewart D"], "date": "2012-10-01T00:00:00Z", "doi": "10.1007/s11096-012-9668-5", "meta_date_publication": "2012 Oct", "meta_volume": "34", "meta_issue": "5", "meta_pages": "733-8", "score": 50057.586, "text_hl": "...BACKGROUND: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ 10 mg was reclassified in 2004 to over-the-counter (OTC) status in the UK, indicated for the prevention of a first major @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary event@@@ in individuals at moderate risk of the event. ", "citations": {"NLM": "Paudyal V, Hansford D, Cunningham S, Stewart D. Pharmacists' perceived integration into practice of over-the-counter simvastatin five years post reclassification. Int J Clin Pharm. 2012 Oct;34(5):733-8. PMID: 22740232", "BibTeX": "@article{22740232, title={Pharmacists' perceived integration into practice of over-the-counter simvastatin five years post reclassification.}, author={Paudyal V and Hansford D and Cunningham S and Stewart D}, journal={Int J Clin Pharm}, volume={34}, number={5}, pages={733-8}}"}}, {"_id": "16710086", "pmid": 16710086, "title": "Effect of simvastatin on coronary lesion site remodeling: a serial intravascular ultrasound study.", "journal": "Cardiology", "authors": ["Jensen LO", "Thayssen P", "Mintz GS", "Carlier SG", "Pedersen KE", "Haghfelt T"], "date": "2006-01-01T00:00:00Z", "doi": "10.1159/000093367", "meta_date_publication": "2006", "meta_volume": "106", "meta_issue": "4", "meta_pages": "256-63", "score": 50056.383, "text_hl": "The aim of the study was to assess the effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary remodeling@@@ in serial intravascular ultrasound (IVUS) studies. ", "citations": {"NLM": "Jensen LO, Thayssen P, Mintz GS, Carlier SG, Pedersen KE, Haghfelt T. Effect of simvastatin on coronary lesion site remodeling: a serial intravascular ultrasound study. Cardiology. 2006;106(4):256-63. PMID: 16710086", "BibTeX": "@article{16710086, title={Effect of simvastatin on coronary lesion site remodeling: a serial intravascular ultrasound study.}, author={Jensen LO and Thayssen P and Mintz GS and Carlier SG and Pedersen KE and Haghfelt T}, journal={Cardiology}, volume={106}, number={4}, pages={256-63}}"}}, {"_id": "19018143", "pmid": 19018143, "title": "Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.", "journal": "Cardiology", "authors": ["Brudi P", "Reckless JP", "Henry DP", "Pomykaj T", "Lim ST", "Massaad R", "Vandormael K", "Johnson-Levonas AO"], "date": "2009-01-01T00:00:00Z", "doi": "10.1159/000172795", "meta_date_publication": "2009", "meta_volume": "113", "meta_issue": "2", "meta_pages": "89-97", "score": 50056.12, "text_hl": "Efficacy of @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in @SPECIES_9606 @@@patients@@@ with a recent @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary@@@ event.", "citations": {"NLM": "Brudi P, Reckless JP, Henry DP, Pomykaj T, Lim ST, Massaad R, Vandormael K, Johnson-Levonas AO. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event. Cardiology. 2009;113(2):89-97. PMID: 19018143", "BibTeX": "@article{19018143, title={Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.}, author={Brudi P and Reckless JP and Henry DP and Pomykaj T and Lim ST and Massaad R and Vandormael K and Johnson-Levonas AO}, journal={Cardiology}, volume={113}, number={2}, pages={89-97}}"}}, {"_id": "19284399", "pmid": 19284399, "title": "The statins in prevention of coronary heart diseases in type 2 diabetics.", "journal": "Bosn J Basic Med Sci", "authors": ["Heljić B", "Velija-Asimi Z", "Kulić M"], "date": "2009-02-01T00:00:00Z", "doi": "10.17305/bjbms.2009.2860", "meta_date_publication": "2009 Feb", "meta_volume": "9", "meta_issue": "1", "meta_pages": "71-6", "score": 50055.25, "text_hl": "@<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@Coronary@@@ revascularizations were 4 in the placebo group and 1 in the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ group. ", "citations": {"NLM": "Heljić B, Velija-Asimi Z, Kulić M. The statins in prevention of coronary heart diseases in type 2 diabetics. Bosn J Basic Med Sci. 2009 Feb;9(1):71-6. PMID: 19284399", "BibTeX": "@article{19284399, title={The statins in prevention of coronary heart diseases in type 2 diabetics.}, author={Heljić B and Velija-Asimi Z and Kulić M}, journal={Bosn J Basic Med Sci}, volume={9}, number={1}, pages={71-6}}"}}, {"_id": "16765358", "pmid": 16765358, "title": "Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).", "journal": "Atherosclerosis", "authors": ["Oikawa S", "Kita T", "Mabuchi H", "Matsuzaki M", "Matsuzawa Y", "Nakaya N", "Saito Y", "Sasaki J", "Shimamoto K", "Itakura H", "J-LIT Study Group"], "date": "2007-04-01T00:00:00Z", "doi": "10.1016/j.atherosclerosis.2006.04.017", "meta_date_publication": "2007 Apr", "meta_volume": "191", "meta_issue": "2", "meta_pages": "440-6", "score": 50055.06, "text_hl": "Risk of @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary@@@ events in Japanese @SPECIES_9606 @@@patients@@@ with both @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@ and @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ on low-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ therapy: implication from Japan @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@Lipid@@@ Intervention Trial (J-LIT).", "citations": {"NLM": "Oikawa S, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Saito Y, Sasaki J, Shimamoto K, Itakura H, J-LIT Study Group. Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT). Atherosclerosis. 2007 Apr;191(2):440-6. PMID: 16765358", "BibTeX": "@article{16765358, title={Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).}, author={Oikawa S and Kita T and Mabuchi H and Matsuzaki M and Matsuzawa Y and Nakaya N and Saito Y and Sasaki J and Shimamoto K and Itakura H and J-LIT Study Group}, journal={Atherosclerosis}, volume={191}, number={2}, pages={440-6}}"}}, {"_id": "19443679", "pmid": 19443679, "title": "The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study.", "journal": "J Clin Pharmacol", "authors": ["Meaney A", "Ceballos G", "Asbun J", "Solache G", "Mendoza E", "Vela A", "Meaney E"], "date": "2009-07-01T00:00:00Z", "doi": "10.1177/0091270009337011", "meta_date_publication": "2009 Jul", "meta_volume": "49", "meta_issue": "7", "meta_pages": "838-47", "score": 50052.746, "text_hl": "Ninety high-risk @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary@@@ @SPECIES_9606 @@@patients@@@ were allocated to 3 groups: @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ 40 mg, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 20 mg and @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ 10 mg initially. ", "citations": {"NLM": "Meaney A, Ceballos G, Asbun J, Solache G, Mendoza E, Vela A, Meaney E. The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study. J Clin Pharmacol. 2009 Jul;49(7):838-47. PMID: 19443679", "BibTeX": "@article{19443679, title={The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study.}, author={Meaney A and Ceballos G and Asbun J and Solache G and Mendoza E and Vela A and Meaney E}, journal={J Clin Pharmacol}, volume={49}, number={7}, pages={838-47}}"}}]}